Author’s view: Radiation and immunotherapy as systemic therapy for solid tumors

OncoImmunology

Volumn 4, Issue 3, 2015, Pages 1-3

  Seyedin, Steven N ^a   Tang, Chad ^a   Welsh, James W ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Abscopal effect; Antibodies; CTLA4; Immune checkpoint inhibitors; PD1; PDL1; Radiation therapy

Indexed keywords

GALECTIN 1; IPILIMUMAB; NIVOLUMAB; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CD8+ T LYMPHOCYTE; CLINICAL TRIAL (TOPIC); COLORECTAL CARCINOMA; EVENT FREE SURVIVAL; HUMAN; LUNG METASTASIS; NON SMALL CELL LUNG CANCER; NONHUMAN; OVERALL SURVIVAL; PROTEIN EXPRESSION; RADIATION DOSE; SIGNAL TRANSDUCTION; SOLID TUMOR; SYSTEMIC THERAPY; TUMOR ESCAPE; TUMOR MICROENVIRONMENT; TUMOR REGRESSION;

EID: 84954466729     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/2162402X.2014.986402     Document Type: Article

References (10)

1. Tang C, Wang X, Soh H, Seyedin S, Cortez MA, Krishnan S, Massarelli E, Hong D, Naing A, Diab A, et al. Combining radiation and immunotherapy: a new systemic therapy for solid tumors? Cancer Immunol Res 2014; 2:831-8; PMID:25187273; http://dx.doi.org/10.1158/2326-6066.CIR-14-0069
2. Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst 2013; 105:256-65; PMID:23291374; http://dx.doi.org/10.1093/jnci/djs629
3. Deng L, Liang H, Burnette B, Beckett M, Darga T, Weichselbaum RR, Fu YX. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest 2014; 124:687-95; PMID: 24382348; http://dx.doi.org/10.1172/JCI67313
4. Lee Y, Auh SL, Wang Y, Burnette B, Wang Y, Meng Y, Beckett M, Sharma R, Chin R, Tu T, et al. Therapeutic effects of ablative radiation on local tumor require CD8C T cells: changing strategies for cancer treatment. Blood 2009; 114:589-95; PMID:19349616; http://dx.doi.org/10.1182/blood-2009-02-206870
5. Tang C, Liao Z, Gomez D, Levy L, Zhuang Y, Gebremichael RA, Hong DS, Komaki R, Welsh JW. Lymphopenia association with gross tumor volume and lung v5 and its effects on non-small cell lung cancer patient outcomes. Int J Radiat Oncol Biol Phys 2014; 89:1084-91; PMID:25035212; http://dx.doi.org/10.1016/j.ijrobp.2014.04.025
6. Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363:711-23; PMID:20525992; http://dx.doi.org/10.1056/NEJMoa1003466
7. Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012; 366:2443-54; PMID:22658127; http://dx.doi.org/10.1056/NEJMoa1200690
8. Kuo P, Bratman S, Shultz D, von Eyben R, Chan C, Wang Z, Say C, Gupta A, Loo B, Giaccia AJ, et al. Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response. Clin Cancer Res 2014; 20:5558-69; PMID:25189484; http://dx.doi.org/10.1158/1078-0432.CCR-14-1138
9. Postow MA, Callahan MK, Barker CA, Yamada Y, Yuan J, Kitano S, Mu Z, Rasalan T, Adamow M, Ritter E, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 2012; 366:925-31; PMID:22397654; http://dx.doi.org/10.1056/NEJMoa1112824
10. Stafford P, Cichacz Z, Woodbury NW, Johnston SA. Immunosignature system for diagnosis of cancer. Proc Natl Acad Sci U S A 2014; 111:E3072-80; PMID: 25024171; http://dx.doi.org/10.1073/pnas.1409432111